Characterization of Stone Events in Patients With Type 3 Primary Hyperoxaluria.

Muhammad G ArnousLisa VaughanRamila A MehtaPhillip J SchulteJohn C LieskeDawn S Milliner

Published in: The Journal of urology (2023)

Stones impose a lifelong burden on PH3 patients. Reducing urinary calcium oxalate supersaturation may reduce event frequency and surgical intervention.

Keyphrases

end stage renal disease
randomized controlled trial
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
risk factors
patient reported